A 52-year-old man with type 2 diabetes mellitus of 15 years' duration presents with nephrotic-range proteinuria (4.2 g/day) and eGFR of 38 mL/min/1.73m². Kidney biopsy is performed. Light microscopy shows PAS-positive, eosinophilic, acellular rounded nodules in the glomerular mesangium with compression of surrounding capillary loops. The structure marked **A** in the diagram represents these characteristic lesions. Which of the following best describes the pathogenetic mechanism underlying the formation of this structure?
A. Monoclonal light chain deposition in the glomerular basement membrane with nodular sclerosis
B. Chronic hyperglycemia-driven accumulation of advanced glycation end-products (AGEs) and non-enzymatic protein glycation leading to mesangial matrix expansion and nodule formation
C. Immune complex deposition with complement activation causing segmental glomerulonephritis and nodular proliferation
D. Amyloid-β fibril deposition with apple-green birefringence under polarized light microscopy
Explanation
Why option 1 is correct
The structure marked A (Kimmelstiel-Wilson nodule) is the pathognomonic histologic hallmark of diabetic nephropathy, classified as Class III in the Tervaert RPS classification. The nodule forms through chronic hyperglycemia-driven non-enzymatic glycation of proteins, producing advanced glycation end-products (AGEs), activation of protein kinase C, and polyol pathway flux. These mechanisms drive excessive accumulation of PAS-positive mesangial matrix material, resulting in the characteristic acellular, rounded, eosinophilic nodules that compress peripheral capillary loops. This is the fundamental pathogenetic mechanism of diabetic kidney disease and is directly cited in Robbins Pathology and KDIGO DKD guidelines.
Why each distractor is wrong
Option 2 (Immune complex deposition): While immune complexes cause glomerulonephritis with nodular features, they are not the mechanism of Kimmelstiel-Wilson nodule formation. Immune complex disease presents with different immunofluorescence patterns (IgG, IgA, C3 deposits) and lacks the specific PAS-positive acellular mesangial nodules characteristic of diabetic nephropathy.
Option 3 (Monoclonal light chain deposition): Light chain deposition disease (MIDD) can produce nodular glomerulosclerosis that superficially resembles Kimmelstiel-Wilson nodules, but it is distinguished by immunofluorescence showing monoclonal light chain deposits (kappa or lambda) and is not driven by hyperglycemia. This is a key differential diagnosis but does not explain the pathogenesis of diabetic nodules.
Option 4 (Amyloid-β deposition): Amyloidosis produces nodular lesions but is distinguished by Congo red positivity and apple-green birefringence under polarized light. Amyloid nodules are not a feature of diabetic nephropathy and occur in systemic amyloidosis, not chronic hyperglycemia.
High-YieldNEET PG
Kimmelstiel-Wilson nodules = PAS-positive acellular mesangial nodules = pathognomonic for diabetic nephropathy = driven by AGE accumulation from chronic hyperglycemia; distinguish from MIDD (light chain deposits), amyloidosis (Congo red+), and immune complex disease (immunofluorescence pattern).
